EXPRESSION AND PURIFICATION OF RECOMBINANT MAREKS-DISEASE VIRUS SEROTYPE-1 SPECIFIC PHOSPHORYLATED PROTEIN-PP38 IN ESCHERICHIA-COLI

被引:11
作者
ENDOH, D
NIIKURA, M
HIRAI, K
INAGAKI, N
HAYASHI, M
NAKAJIMA, K
SATO, F
机构
[1] UNIV TOKYO,FAC AGR,DEPT MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN
[2] HOKKAIDO UNIV,FAC VET MED,ANIM SCI LAB,SAPPORO,HOKKAIDO 060,JAPAN
[3] TOKYO MED & DENT UNIV,MED RES INST,DEPT CELL REGULAT,DIV VIROL & IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN
[4] NATL RES INST AQUACULTURE,FISHERIES AGCY,PATHOL SECT & FISH PATHOL,NAKATSUHAMA NANSEI,MIE 4221,JAPAN
关键词
MAREKS DISEASE VIRUS; M21 MONOCLONAL ANTIBODY; NI-TAG; PHOSPHORYLATED PROTEIN; RECOMBINANT PP38;
D O I
10.1292/jvms.56.823
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Phosphorylated protein pp38 is the only protein that is detected in the Marek's disease (MD) lymphoma caused by MD virus serotype 1 (MDV-1) and lymphoblastoid cell lines. In this study, a recombinant protein coded for by the almost entire open reading frame of the MDV-1 pp38 cDNA was produced in E. coli and purified by affinity chromatography. Prior to the expression and purification of the protein, cDNA containing the entire coding region for pp38 was cloned and its nucleotide sequence was determined. Immunoblot analysis indicated that the expressed recombinant protein electrophoresed close to that of the pp38 in infected cells. The difference in mobility of the purified recombinant and the pp38 in infected cells corresponded to a fusion peptide. The recombinant pp38 may be of interest for function analyses and the diagnotic use of pp38.
引用
收藏
页码:823 / 826
页数:4
相关论文
共 21 条
[1]   LOSS OF MAREKS-DISEASE VIRUS TUMORIGENICITY IS ASSOCIATED WITH TRUNCATION OF RNAS TRANSCRIBED WITHIN BAMHI-H [J].
BRADLEY, G ;
LANCZ, G ;
TANAKA, A ;
NONOYAMA, M .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4129-4135
[2]  
CALNEK BW, 1986, CRC CR REV MICROBIOL, V12, P293
[3]   IDENTIFICATION OF A UNIQUE MAREKS-DISEASE VIRUS GENE WHICH ENCODES A 38-KILODALTON PHOSPHOPROTEIN AND IS EXPRESSED IN BOTH LYTICALLY INFECTED-CELLS AND LATENTLY INFECTED LYMPHOBLASTOID TUMOR-CELLS [J].
CHEN, XB ;
SONDERMEIJER, PJA ;
VELICER, LF .
JOURNAL OF VIROLOGY, 1992, 66 (01) :85-94
[4]   IDENTIFICATION AND MAPPING OF DIMERIZATION AND DNA-BINDING DOMAINS IN THE C-TERMINUS OF THE IE2 REGULATORY PROTEIN OF HUMAN CYTOMEGALOVIRUS [J].
CHIOU, CJ ;
ZONG, JC ;
WAHEED, I ;
HAYWARD, GS .
JOURNAL OF VIROLOGY, 1993, 67 (10) :6201-6214
[5]  
Cui Z Z, 1990, Virus Genes, V3, P309, DOI 10.1007/BF00569038
[6]   STRUCTURAL-ANALYSIS AND TRANSCRIPTIONAL MAPPING OF THE MAREKS-DISEASE VIRUS GENE ENCODING PP38, AN ANTIGEN ASSOCIATED WITH TRANSFORMED-CELLS [J].
CUI, ZZ ;
LEE, LF ;
LIU, JL ;
KUNG, HJ .
JOURNAL OF VIROLOGY, 1991, 65 (12) :6509-6515
[7]   A NOVEL SEQUENTIAL PROCEDURE TO ENHANCE THE RENATURATION OF RECOMBINANT PROTEIN FROM ESCHERICHIA-COLI INCLUSION-BODIES [J].
FISCHER, B ;
PERRY, B ;
SUMNER, I ;
GOODENOUGH, P .
PROTEIN ENGINEERING, 1992, 5 (06) :593-596
[8]   STRUCTURE OF MAREKS-DISEASE VIRUS-DNA - DETAILED RESTRICTION ENZYME MAP [J].
FUKUCHI, K ;
SUDO, M ;
LEE, YS ;
TANAKA, A ;
NONOYAMA, M .
JOURNAL OF VIROLOGY, 1984, 51 (01) :102-109
[9]   GENETIC APPROACH TO FACILITATE PURIFICATION OF RECOMBINANT PROTEINS WITH A NOVEL METAL CHELATE ADSORBENT [J].
HOCHULI, E ;
BANNWARTH, W ;
DOBELI, H ;
GENTZ, R ;
STUBER, D .
BIO-TECHNOLOGY, 1988, 6 (11) :1321-1325
[10]   IDENTIFICATION OF MAREKS-DISEASE VIRUS-SPECIFIC ANTIGENS IN MAREKS-DISEASE LYMPHOBLASTOID CELL-LINES USING MONOCLONAL-ANTIBODY AGAINST VIRUS-SPECIFIC PHOSPHORYLATED POLYPEPTIDES [J].
IKUTA, K ;
NAKAJIMA, K ;
NAITO, M ;
ANN, SH ;
UEDA, S ;
KATO, S ;
HIRAI, K .
INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (02) :257-264